These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


568 related items for PubMed ID: 9537870

  • 21. [Treatment of obstetric cholestasis with polyunsaturated phosphatidylcholine and ursodeoxycholic acid].
    Marciniak B, Kimber-Trojnar Z, Leszczyńska-Gorzelak B, Patro-Małysza J, Trojnar M, Oleszczuk J.
    Ginekol Pol; 2011 Jan; 82(1):26-31. PubMed ID: 21473053
    [Abstract] [Full Text] [Related]

  • 22. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal.
    Brites D, Rodrigues CM, van-Zeller H, Brito A, Silva R.
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):31-8. PubMed ID: 9758256
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
    Mikucka-Niczyporuk A, Pierzynski P, Lemancewicz A, Kosinski P, Charkiewicz K, Knas M, Kacerovsky M, Blachnio-Zabielska A, Laudanski P.
    Prostaglandins Other Lipid Mediat; 2020 Apr 29; 147():106399. PubMed ID: 31733339
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical grading of intrahepatic cholestasis pregnancy.
    Pradhan M, Shao Y.
    JNMA J Nepal Med Assoc; 2013 Apr 29; 52(190):413-9. PubMed ID: 24362672
    [Abstract] [Full Text] [Related]

  • 34. [Influence of pharmacological treatment on selected parameters of intrahepatic cholestasis of pregnancy].
    Brzozowska M, Kowalska-Koprek U, Karowicz-Bilińska A.
    Ginekol Pol; 2010 Feb 29; 81(2):94-8. PubMed ID: 20232705
    [Abstract] [Full Text] [Related]

  • 35. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B, Özler S.
    Hepatobiliary Pancreat Dis Int; 2020 Jun 29; 19(3):271-276. PubMed ID: 31919038
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Intrahepatic cholestasis of pregnancy: review].
    Medina Lomelí JM, Jáuregui Meléndrez RA, Medina Castro N, Medina Castro D.
    Ginecol Obstet Mex; 2012 Apr 29; 80(4):285-94. PubMed ID: 22808859
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.